The American Journal of Cardiology

Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study)
pp. 925-930(6)
Authors: Montalescot G.; Bal-dit-Sollier C.; Chibedi D.; Collet J.-P.; Soulat T.; Dalby M.; Choussat R.e.; Cohen A.; Slama M.; Steg P.G.; Dubois-Rande J.-L.; Metzger J.-P.; Tarragano F.; Guermonprez J.L.; Drouet L.; ARMADA Investigators

Impact of high-sensitivity c-reactive protein on predicting long-term mortality of acute myocardial infarction
pp. 931-935(5)
Authors: Kinjo K.; Sato H.; Ohnishi Y.; Hishida E.; Nakatani D.; Mizuno H.; Imai K.; Nanto S.; Naka M.; Matsumura Y.; Takeda H.; Hori M.; Osaka Acute Coronary Insufficiency Study OACIS Group

Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes
pp. 936-940(5)
Authors: Rao S.V.; Ohman E.M.; Granger C.B.; Armstrong P.W.; Gibler W.B.; Christenson R.H.; Hasselblad V.; Stebbins A.; McNulty S.; Newby L.K.

Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest pain
pp. 941-945(5)
Authors: Cortigiani L.; Coletta C.; Bigi R.; Amici E.; Desideri A.; Odoguardi L.

A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention
pp. 946-950(5)
Authors: Vakili B.A.; Kaplan R.C.; Slater J.N.; Sherman W.; Ravi K.L.; Green S.J.; Sanborn T.A.; Brown D.L.

Immediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectoris
pp. 951-955(5)
Authors: Di Pede F.; Lanza G.A.; Zuin G.; Alfieri O.; Rapati M.; Romano M.; Circo A.; Cardano P.; Bellocci F.; Santini M.; Maseri A.; Investigators of the Prospective Italian Registry of SCS for Angina Pectoris

Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome
pp. 956-960(5)
Authors: Vega G.L.; Ma P.T.S.; Cater N.B.; Filipchuk N.; Meguro S.; Garcia-Garcia A.B.; Grundy S.M.

Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia
pp. 961-964(4)
Authors: Lucas C.P.; Boldrin M.N.; Reaven G.M.

Comparison of subjective perception of myocardial ischemia produced by coronary balloon occlusion in patients with versus those without type 2 diabetes mellitus
pp. 965-968(4)
Authors: McNulty P.H.; Ettinger S.M.; Gascho J.; Gilchrist I.C.; Piracha A.; Kozak M.; Chambers C.E.

Association between gender and In-Hospital mortality after percutaneous coronary intervention according to age
pp. 968-971(4)
Authors: Abramson J.L.; Veledar E.; Weintraub W.S.; Vaccarino V.

Predictors of progression of native coronary narrowing to total occlusion after coronary artery bypass grafting
pp. 971-974(4)
Authors: Pond K.K.; Martin G.V.; Every N.; Lehmann K.G.; Anderson R.; Caldwell J.H.; Kapadia S.R.

Gadolinium-enhanced coronary angiography in patients with impaired renal function
pp. 974-975(2)
Authors: Sarkis A.; Badaoui G.; Azar R.; Sleilaty G.; Bassil R.; Jebara V.A.

Association of an activated clotting time =<250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy)
pp. 976-978(3)
Authors: Pinto D.S.; Lorenz D.P.; Murphy S.A.; Marble S.J.; DiBattiste P.M.; Demopoulos L.A.; Cannon C.P.; Gibson C.M.; TIMI Study Group

Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries
pp. 979-981(3)
Authors: Ashby D.T.; Mehran R.; Aymong E.A.; Lansky A.J.; Iakovou I.; Weisz G.; New G.; Moussa I.; Dangas G.; Moses J.W.; Stone G.W.; Leon M.B.

Chlamydia pneumoniae antibodies and endothelial function as assessed by flow-mediated dilation in patients with chest pain with and without ischemic heart disease
pp. 982-985(4)
Authors: Malmqvist B.B.; Diness B.R.; Krogsgaard K.; Thomassen L.H.; Jensen G.B.; IAMA Group

Outcomes in patients with coronary heart disease who do not undergo lipid testing
pp. 986-988(3)
Authors: Ho P.M.; Maynard C.; Starks H.; Sun H.; Sloan K.; Sales A.

Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty
pp. 989-991(3)
Authors: Khan M.A.; Hlatky M.A.; Liu M.W.; Lin F.; Rogers W.J.; Shlipak M.G.; HERS Investigators

Volumetric assessment of ulcerated ruptured coronary plaques with three-dimensional intravascular ultrasound in vivo
pp. 992-996(5)
Authors: Gossl M.; von Birgelen C.; Mintz G.S.; Bose D.; Eggebrecht H.; Baumgart D.; Haude M.; Erbel R.

Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia
pp. 996-999(4)
Authors: Gulec S.; Atmaca Y.; Kilickap M.; Akyurek O.; Aras O.; Oral D.

Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin
pp. 999-1002(4)
Authors: Abourjaily H.M.; Alsheikh-Ali A.A.; Karas R.H.

Factors associated with ventricular inducibility in the MADIT-II study population
pp. 1002-1004(3)
Authors: Sesselberg H.W.; Moss A.J.; Steinberg J.; Carroll E.; Zareba W.; Daubert J.; Huang D.T.

Effect of interatrial block on coronary sinus contraction
pp. 1004-1006(3)
Authors: Farah H.H.; Spodick D.H.

Prevalence and triggers of syncope in medical students
pp. 1006-1008(3)
Authors: Ganzeboom K.S.; Colman N.; Reitsma J.B.; Shen W.K.; Wieling W.

Effect of exercise training on blood pressure in postmenopausal Caucasian and African-American women
pp. 1009-1011(3)
Authors: Santa-Clara H.; Szymanski L.; Fernhall B.o.

Influence of co-morbidity on cost of care for heart failure
pp. 1011-1015(5)
Authors: Weintraub W.S.; Kawabata H.; Tran M.; L'Italien G.J.; Chen R.S.

Diagnostic challenges defining heart failure when using echocardiograms
pp. 1015-1017(3)
Authors: Subramanian U.; Weinberger M.; Fihn S.D.; Tierney W.M.

Percutaneous transvenous mitral valvulotomy normalizes elevated circulating levels of tumor necrosis factor- and interleukin-6 in mitral stenosis with heart failure
pp. 1018-1020(3)
Authors: Chang C.-J.; Hsu L.-A.n.; Chiang C.-W.; Ko Y.u.-S.; See L.-C.; Shen Y.-C.; Ko Y.u.-L.; Kou C.-T.; Lee Y.-S.; Pang J.-H.S.

Screening for hypertrophic cardiomyopathy in a young male military population
pp. 1021-1023(3)
Authors: Nistri S.; Thiene G.; Basso C.; Corrado D.; Vitolo A.; Maron B.J.

Serum levels of matrix metalloproteinases and tumor necrosis factor- in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels
pp. 1024-1027(4)
Authors: Ohtsuka T.; Hamada M.; Saeki H.; Ogimoto A.; Hara Y.; Shigematsu Y.; Higaki J.

Reliability of intraoperative contrast transesophageal echocardography for detecting interatrial communications in patients with other congenital cardiovascular malformations
pp. 1027-1031(5)
Authors: Cassorla L.; Miller-Hance W.C.; Rouine-Rapp K.; Reddy V.M.; Hanley F.L.; Silverman N.H.

Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease
pp. 1031-1032(2)
Authors: Ringel R.E.; Peddy S.B.

Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension
pp. 1033-1037(5)
Authors: Hinderliter A.L.; Willis P.W.; Long W.A.; Clarke W.R.; Ralph D.; Caldwell E.J.; Williams W.; Ettinger N.A.; Hill N.S.; Summer W.R.; de Boisblanc B.; Koch G.; Li S.; Clayton L.M.; Jobsis M.M.; Crow J.W.; PPH Study Group

Comparison of accuracy of left ventricular echocardiographic measurements by fundamental imaging versus second harmonic imaging
pp. 1037-1039(3)
Authors: Mansencal N.; Bordachar P.; Chatellier G.; Redheuil A.; Diebold B.; Abergel E.

Does living alone affect the outcome of acute myocardial infarction?
pp. 1040-1040(1)
Authors: Freedland K.E.; Carney R.M.